15.02.2016 Views

CANCER

1PMPyU0

1PMPyU0

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Bloodwise 11<br />

STRATEGIC REPORT<br />

HIDING FROM THE IMMUNE POLICE<br />

Many cells, such as white blood cells,<br />

patrol the body to seek out foreign<br />

invaders or rogue cells and flag them for<br />

destruction. To avoid this, cancer cells may<br />

send out ‘I’m friendly’ signals to make them invisible<br />

to the immune system. Scientists are developing ways<br />

to unveil this invisibility cloak to usher in a killer<br />

immune attack.<br />

Professor Francesco Dazzi at Kings College London<br />

has a £1 million programme to develop ways, using<br />

different facets of the immune system, to overcome<br />

this immune cloaking to unleash a killer response.<br />

These sorts of approaches have the potential to be<br />

truly personalised.<br />

We’re also supporting early stage clinical trials in<br />

Oxford and Southampton to test new modified immune<br />

proteins that stick to leukaemia or lymphoma cells and<br />

flag them to other killer white blood cells.<br />

THE HALLMARKS OF <strong>CANCER</strong><br />

IGNORING THE RED LIGHT<br />

Cells are constantly monitoring and<br />

receiving signals from the surrounding<br />

environment. The signals determine when new cells<br />

are needed and when growth should be stopped. These<br />

provide a counter-balance to the ‘go’ signals and make<br />

sure cells are put in sleep mode at the right times.<br />

Cancer cells acquire genetic faults that mean they are<br />

insensitive to growth-preventing signals from their<br />

neighbours that normally act as safety valves against<br />

uncontrolled cell growth.<br />

Dr Jonathan Strefford at the University of Southampton<br />

has a £250,000 project that will use cultured and<br />

isolated leukaemia cells to discover how faults in a key<br />

protein prevent chronic lymphocytic leukaemia (CLL)<br />

cells from being pushed to cell death by surrounding<br />

signals or drugs. This will help us better understand<br />

disease progression and to develop ways to overcome<br />

drug resistance.<br />

ENDLESS NEW CELLS<br />

Chromosomes – the packets of genetic<br />

material in our cells – have protective<br />

caps at their ends, like the plastic at the<br />

ends of shoelaces. As normal cells grow<br />

and divide, these protective caps get nibbled away.<br />

When they get too short, the cell enters sleep mode or<br />

activates its cell death program. This means normal<br />

cells have a finite limit on the number of divisions –<br />

another safety mechanism to prevent uncontrolled<br />

growth.<br />

Certain genetic faults, however, can cause overactivation<br />

of proteins that keep lengthening the<br />

protective caps, meaning they’re capable of limitless<br />

growth and division. The DNA in these immortal cells<br />

become more and more damaged over time, leading to<br />

cancer.<br />

When a protein called NF-kB switches on it triggers a<br />

cell to multiply. Faults in this protein can cause it to<br />

become permanently active, pushing the cell towards<br />

endless growth. Professor Guido Franzoso’s team<br />

Bloodwise trading as Leukaemia & Lymphoma Research Company limited by guarantee 738089<br />

Registered charity 216032 (England & Wales) SC037529 (Scotland)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!